Montelukast Prescribing at SOUTH VIEW PARTNERSHIP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
241
Total Quantity
10.4K
NHS Cost
£579
vs National Avg
-64.8%
SOUTH VIEW PARTNERSHIP prescribed 241 items of Montelukast over the last 12 months at a cost of £579 to the NHS. This is 64.8% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
19
Jul 2026
28
Jul 2026
16
Jul 2026
17
Jul 2026
21
Jul 2026
16
Jul 2026
16
Jul 2026
27
Jul 2026
17
Jul 2026
25
Jul 2026
18
Jul 2026
21
Prescribing Details
| Total Items | 241 |
|---|---|
| Total Quantity | 10,430 |
| Total NHS Cost | £579 |
| Presentations | 4 different forms |
| vs National Average | -64.8% |
Montelukast Prescribing Comparison
| This practice | 241 items |
|---|---|
| National average per practice | 685 items |
| Difference | -64.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.